Anirban

Riscosity - Third-Party Data Observability Pioneer - Closes $7M of New Funding

Retrieved on: 
Tuesday, April 25, 2023
Investment, Policy, Political lists, Risk management, SBOM, Risk, Apache, Software Composition Analysis, Privacy, SCA, Anirban, GDPR, Entrepreneurship, Cloudflare, Glass, Legislation, Software, Cryptocurrency, Online shopping, SolarWinds, Kaseya VSA ransomware attack

AUSTIN, Texas, April 25, 2023 /PRNewswire-PRWeb/ -- Riscosity—a leading software platform revolutionizing risk management and mitigation across enterprise data supply chains—today announced $7M of new funding. The financing was led by S3 Ventures with participation from Secure Octane Investments, Firebolt Ventures, and several cybersecurity executives.This investment accelerates the company's ability to grow its team, expand its Third-Party Data Observability (TPDO) platform, and serve its growing base of large enterprise customers.

Key Points: 
  • Austin and San Francisco-based Riscosity—maker of leading Third-Party Data Observability (TPDO) platform—today announced $7M of new funding.
  • AUSTIN, Texas, April 25, 2023 /PRNewswire-PRWeb/ -- Riscosity—a leading software platform revolutionizing risk management and mitigation across enterprise data supply chains—today announced $7M of new funding.
  • "Riscosity gets organizations from zero to 100% third-party data observability in just a few minutes.
  • To understand more about the solution that Riscosity provides, please connect with the company at https://www.riscosity.com and at +1-888-747-2674 (+1-888-RISCOSI)

Bloomreach Appoints Anirban Bardalaye as Chief Product Officer

Retrieved on: 
Tuesday, September 13, 2022
Cloud, Certification, Guy-wire, Magic, Puma, CDP, Serena Software, Product management, Marks & Spencer, CMS, Albertsons, Growth, Industry, National Institutes of Technology, Content, Commerce, Head, Automation, CEO, Louisiana State University, MBA, Solution, University of Chicago Booth School of Business, Leadership, Anirban, Mechanical, Mechanical engineering, Business process management, Marketing, University, Business process, Software as a service, Y Combinator, National Institute, Management, Online shopping, Salesforce, Engagement

MOUNTAIN VIEW, Calif., Sept. 13, 2022 /PRNewswire/ -- Bloomreach, the world's #1 Commerce Experience Cloud, today announced it has appointed Anirban Bardalaye as Chief Product Officer, effective immediately. In this role, Anirban will further accelerate the growth of the company's three product pillars — Discovery, Engagement, and Content — as it continues to scale its Commerce Experience Cloud to serve businesses around the world. Anirban previously served as Vice President of Product Management, Commerce Cloud, at Salesforce, and in addition to his success as a Y Combinator-backed entrepreneur, has nearly 15 years of experience leading product strategy for SaaS companies. 

Key Points: 
  • With Extensive Experience in SaaS Product Leadership,
    MOUNTAIN VIEW, Calif., Sept. 13, 2022 /PRNewswire/ -- Bloomreach , the world's #1 Commerce Experience Cloud, today announced it has appointed Anirban Bardalaye as Chief Product Officer, effective immediately.
  • "We're thrilled to have Anirban joining the team to lead Bloomreach into its next era of product leadership," said Raj De Datta, co-founder and CEO, Bloomreach.
  • "Bloomreach has made massive strides in product innovation these past few years alone, and now, it's poised to further redefine what an incredible commerce experience can achieve for businesses when driven by the right technology," said Anirban Bardalaye.
  • Anirban Bardalaye has served as Vice President of Product Management, Commerce Cloud, at Salesforce since 2019.

Modular Building Institute Brings In Anirban Basu as Industry Chief Economist

Retrieved on: 
Monday, August 15, 2022
Multimedia, Human voice, CEO, Anirban, Face, Association, Education, Modular building, Built environment, World, MBI, Commercial modular construction, Media contacts database, Self storage, MD

CHARLOTTESVILLE, Va., Aug. 15, 2022 /PRNewswire/ -- The Modular Building Institute (MBI)—the world's largest trade association for the commercial modular construction industry—is excited to announce that Anirban Basu, chairman and CEO of Baltimore-based Sage Policy Group, is now MBI's chief economist.

Key Points: 
  • CHARLOTTESVILLE, Va., Aug. 15, 2022 /PRNewswire/ --The Modular Building Institute (MBI)the world's largest trade association for the commercial modular construction industryis excited to announce that Anirban Basu, chairman and CEO of Baltimore-based Sage Policy Group, is now MBI's chief economist.
  • The Modular Building Institute adds Dr. Anirban Basu as trade associations' chief economist.
  • "We're thrilled have Anirban join MBI as the modular construction industry's new chief economist," says Tom Hardiman, executive director of the Modular Building Institute.
  • About the Modular Building Institute: Founded in 1983, the Modular Building Institute (MBI) is the international non-profit trade association serving modular construction.

UNITY Biotechnology Appoints Mike Sapieha, Ph.D., as Chief Scientific Advisor

Retrieved on: 
Monday, February 1, 2021
Anirvan Ghosh, Bengali people, California, Anirban, Unity Biotechnology, Ghosh, Unity Technologies, Biotechnology, South Asian people

UNITY also names Jason Damiano, Ph.D., as vice president of translational biology and Nathan Guz, Ph.D., as vice president of operations

Key Points: 
  • UNITY also names Jason Damiano, Ph.D., as vice president of translational biology and Nathan Guz, Ph.D., as vice president of operations
    SOUTH SAN FRANCISCO, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced the appointment of Przemyslaw (Mike) Sapieha, Ph.D., as chief scientific advisor.
  • Mike is a long-term UNITY collaborator and an outstanding scientist whose work on the biological pathways impacting age-related eye diseases has been instrumental in the advancement of our Bcl-xL inhibitor, UBX1325, into the clinic, said Anirvan Ghosh, Ph.D., chief executive officer of UNITY.
  • I am looking forward to joining Anirvan and the UNITY team to contribute to the realization of that vision.
  • I am pleased to welcome Mike, Jason, and Nate to our leadership team as we drive UNITY forward.

UNITY Biotechnology Announces CFO Transition

Retrieved on: 
Monday, July 6, 2020
Branches of biology, Biology, Senescence, Cell biology, Unity Biotechnology, Senolytic, Cellular senescence, Biotechnology, Anirban, Nathaniel David

SAN FRANCISCO, July 06, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Bob Goeltz, chief financial officer, will leave the company at the end of July 2020 to pursue a new opportunity.

Key Points: 
  • SAN FRANCISCO, July 06, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Bob Goeltz, chief financial officer, will leave the company at the end of July 2020 to pursue a new opportunity.
  • I want to thank Bob for his many contributions and wish him success in his next endeavors, said Anirvan Ghosh, Ph.D., chief executive officer of UNITY.
  • I have been impressed by the bold vision and the advancement of the drug development programs at UNITY, and this is a vital time to get involved.
  • UNITY is developing senolytic medicines to eliminate senescent cells and thereby stop the production of the SASP, which UNITY believes addresses a root cause of age-related diseases.

UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates

Retrieved on: 
Thursday, May 7, 2020
Anirban, Academic term

During the first quarter, we sustained strong momentum on our UBX0101 development program, said Anirvan Ghosh, chief executive officer of UNITY.

Key Points: 
  • During the first quarter, we sustained strong momentum on our UBX0101 development program, said Anirvan Ghosh, chief executive officer of UNITY.
  • Consistent with prior guidance, both 12- and 24-week results are expected in the second half of 2020.
  • In March 2020, UNITY announced completion of enrollment of a Phase 1b study of UBX010 in patients with moderate-to-severe OA of the knee.
  • Consistent with prior guidance, both 12- and 24-week results are expected in the second half of 2020.

UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer

Retrieved on: 
Monday, March 2, 2020
Bengali people, Surname, Software, Humans, Bengali Hindus, Anirban, Anirvan, Unity, Biogen, Ghosh

Dr. Ghosh joins UNITY from Biogen, where he served as Senior Vice President, Head of Research and Early Development.

Key Points: 
  • Dr. Ghosh joins UNITY from Biogen, where he served as Senior Vice President, Head of Research and Early Development.
  • Augmenting our already strong executive team with Anirvans insights and experience will ensure that UNITY has the opportunity to realize its full potential.
  • I look forward to continuing the journey and providing important continuity as I work with Anirvan in my capacity as Chairman.
  • UNITY President and co-founder, Nathaniel (Ned) E. David, Ph.D. added, I am really excited to work with Anirvan.

Anirban Dasgupta joins Equiteq as Managing Director, Buy-side & Market Intelligence

Retrieved on: 
Wednesday, February 26, 2020
Economy, Articles, Business, Corporate finance, Investment, Private equity, Market intelligence, Anirban, Entrepreneurship

Equiteq offers unrivalled support through its global footprint, sector focus, multi-disciplinary resources and long-term engagement model.

Key Points: 
  • Equiteq offers unrivalled support through its global footprint, sector focus, multi-disciplinary resources and long-term engagement model.
  • Based in New York, Anirban will lead Equiteq's buy-side and market intelligence practice in the region, driving specialist insight into the increasingly mature and competitive community of entrepreneurs, strategic acquirers and private equity firms looking to transact in the knowledge economy.
  • Anirban Dasguptasaid, "I am pleased to be joining Equiteq at a pivotal time in the company's growth journey.
  • Paul Dondos, Global Head of Buy-side and Market Intelligence at Equiteq, said, "We are delighted to welcome Anirban onto the platform at this very exciting time for our buy-side offering.

Anirban Dasgupta joins Equiteq as Managing Director, Buy-side & Market Intelligence

Retrieved on: 
Wednesday, February 26, 2020
Economy, Articles, Business, Corporate finance, Investment, Private equity, Market intelligence, Anirban, Entrepreneurship

Equiteq offers unrivalled support through its global footprint, sector focus, multi-disciplinary resources and long-term engagement model.

Key Points: 
  • Equiteq offers unrivalled support through its global footprint, sector focus, multi-disciplinary resources and long-term engagement model.
  • Based in New York, Anirban will lead Equiteq's buy-side and market intelligence practice in the region, driving specialist insight into the increasingly mature and competitive community of entrepreneurs, strategic acquirers and private equity firms looking to transact in the knowledge economy.
  • Anirban Dasguptasaid, "I am pleased to be joining Equiteq at a pivotal time in the company's growth journey.
  • Paul Dondos, Global Head of Buy-side and Market Intelligence at Equiteq, said, "We are delighted to welcome Anirban onto the platform at this very exciting time for our buy-side offering.